SIREN : 849663661
UROPH is a French company founded 7 years ago, specialized in the sector Activité des médecins généralistes. Based in ANTIBES (06600), this company of category PME shows in 2022 a net income positive of 31 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-07-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.
In summary, UROPH posts positive profitability over the latest financial year. Its financial structure is broadly in line with its sector.
| Indicator | 2022 |
|---|---|
| Revenue | N/C |
| Net income | 30 569 € |
| EBITDA | N/C |
| Net margin | N/C |
In 2022, UROPH generates positive net income of 31 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
30 569 €
The debt ratio (= Financial debt / Equity x 100) stands at 48%. This ratio is slightly less favorable than the sector median (22.1%). Financial autonomy (= Equity / Total assets x 100) reaches 60%. This ratio is slightly less favorable than the sector median (62.7%).
47.89%
59.73%
34.5%
In 2022, the debt ratio of UROPH (47.9%) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2022, the financial autonomy of UROPH (59.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 1.24. This ratio is less favorable than the sector median (3.4) and warrants attention.
1.24
In 2022, the liquidity ratio of UROPH (1.24) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Based on 274 transactions of similar company sales (all years), the value of UROPH is estimated at 121 124 € (range 31 649€ - 297 001€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 274 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare UROPH with other companies in the same sector:
Voir toutes les statistiques du secteur Activité des médecins généralistes
Largest companies by revenue in the sector Activité des médecins généralistes:
Largest companies by revenue in the department Alpes-Maritimes:
The revenue of UROPH is not publicly disclosed (confidential accounts filed with INPI).
Yes, UROPH generated a net profit of 31 k€ in 2022.
The headquarters of UROPH is located in ANTIBES (06600), in the department Alpes-Maritimes.
The tax return of UROPH is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
UROPH operates in the sector Activité des médecins généralistes (NAF code 86.21Z). See the 'Sector positioning' section above to compare the company with its competitors.